Xicheng Wang

6.5k total citations
205 papers, 2.8k citations indexed

About

Xicheng Wang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xicheng Wang has authored 205 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 64 papers in Molecular Biology and 57 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xicheng Wang's work include Colorectal Cancer Treatments and Studies (35 papers), Gastric Cancer Management and Outcomes (26 papers) and Lung Cancer Treatments and Mutations (25 papers). Xicheng Wang is often cited by papers focused on Colorectal Cancer Treatments and Studies (35 papers), Gastric Cancer Management and Outcomes (26 papers) and Lung Cancer Treatments and Mutations (25 papers). Xicheng Wang collaborates with scholars based in China, Ethiopia and United States. Xicheng Wang's co-authors include Lin Shen, Jifang Gong, Ming Lu, Zhi Peng, Jun Zhou, Zhihao Lü, Jian Li, Xiaotian Zhang, Fu‐Sheng Wang and Zheng Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Xicheng Wang

195 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xicheng Wang China 25 1.2k 904 531 528 407 205 2.8k
Kah Keng Wong Malaysia 27 1.3k 1.1× 1.6k 1.8× 506 1.0× 1.1k 2.0× 204 0.5× 111 3.7k
Fang Yu United States 30 527 0.5× 1.2k 1.3× 289 0.5× 180 0.3× 185 0.5× 87 2.6k
Pierre Martineau France 35 900 0.8× 1.9k 2.1× 516 1.0× 279 0.5× 407 1.0× 138 3.7k
Sigrid Hatse Belgium 36 1.8k 1.5× 1.5k 1.6× 1.1k 2.1× 227 0.4× 191 0.5× 97 4.1k
Bing Tian United States 36 615 0.5× 2.1k 2.3× 1.1k 2.2× 413 0.8× 150 0.4× 74 3.9k
Yi‐Lin Chiu United States 21 452 0.4× 1.0k 1.2× 312 0.6× 204 0.4× 227 0.6× 102 2.6k
Susan L. Kelley United States 17 888 0.8× 1.3k 1.5× 642 1.2× 281 0.5× 290 0.7× 26 3.4k
Shigeru Kawabata Japan 18 1.3k 1.2× 1.2k 1.4× 362 0.7× 334 0.6× 207 0.5× 46 2.3k
Anil Tulpule United States 33 2.6k 2.2× 1.6k 1.8× 388 0.7× 216 0.4× 161 0.4× 93 4.6k
Chunyang Li China 28 612 0.5× 984 1.1× 889 1.7× 195 0.4× 236 0.6× 107 2.5k

Countries citing papers authored by Xicheng Wang

Since Specialization
Citations

This map shows the geographic impact of Xicheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xicheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xicheng Wang more than expected).

Fields of papers citing papers by Xicheng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xicheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xicheng Wang. The network helps show where Xicheng Wang may publish in the future.

Co-authorship network of co-authors of Xicheng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xicheng Wang. A scholar is included among the top collaborators of Xicheng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xicheng Wang. Xicheng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qi, Changsong, Chang Liu, Xiaofei Wei, et al.. (2024). Antigen-independent activation is critical for the durable antitumor effect of GUCY2C-targeted CAR-T cells. Journal for ImmunoTherapy of Cancer. 12(10). e009960–e009960. 5 indexed citations
3.
Jia, Keren, Chen Yang, Yi Xie, et al.. (2024). Helicobacter pylori and immunotherapy for gastrointestinal cancer. The Innovation. 5(2). 100561–100561. 33 indexed citations
4.
5.
Zhang, Wencheng, Yangyang Cui, Yuting Li, et al.. (2024). Hormonally and chemically defined expansion conditions for organoids of biliary tree Stem Cells. Bioactive Materials. 41. 672–695. 6 indexed citations
6.
Li, Bin, Haina Yu, Rui Sun, et al.. (2024). Distinct clinical characteristics in stage III rectal cancer among different age groups and treatment outcomes after neoadjuvant chemoradiotherapy. Therapeutic Advances in Medical Oncology. 16. 12674170–12674170.
7.
8.
9.
Xu, Ting, Jian Li, Zhenghang Wang, et al.. (2023). Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer. Cancer Medicine. 12(9). 10473–10484. 9 indexed citations
10.
Zhang, Wencheng, Yongmei Xu, Xicheng Wang, et al.. (2023). Fibrolamellar carcinomas–growth arrested by paracrine signals complexed with synthesized 3-O sulfated heparan sulfate oligosaccharides. Matrix Biology. 121. 194–216. 3 indexed citations
11.
Qin, Shukui, Jin Li, Haijun Zhong, et al.. (2022). Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial. British Journal of Cancer. 127(12). 2241–2248. 15 indexed citations
12.
Peng, Zhi, Siyuan Cheng, Yan Kou, et al.. (2020). The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer. Cancer Immunology Research. 8(10). 1251–1261. 235 indexed citations
13.
14.
Wang, Xicheng, Qing Wei, Jing Gao, et al.. (2017). Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study. Chinese Journal of Cancer. 36(1). 81–81. 14 indexed citations
15.
Wang, Yakun, Xicheng Wang, & Lin Shen. (2016). Clinical characteristics, diagnosis, and treatment of brain metastases from colorectal cancer. 43(21). 962–966. 2 indexed citations
16.
Zhang, Xiaotian, Jifang Gong, Xicheng Wang, et al.. (2014). [Trastuzumab combined with chemotherapy in patients with HER2-positive chemo-refractory advanced gastric or gastro-esophageal junction adenocarcinoma].. PubMed. 36(3). 223–7. 5 indexed citations
17.
Wang, Xicheng. (2013). Isolation,Subcellular Localization and Expression Analysis of Gibberellin Receptor Gene VvGID1A from Grapevine. Acta Horticulturae Sinica. 1 indexed citations
18.
Shangguan, Lingfei, Wang Chen, Jinggui Fang, et al.. (2011). Isolation of Effective Genes with Digital Northern Platform of NCBI Grapevine (Vitis vinifera L.) EST Sequences. Zhongguo nongye Kexue. 44(13). 2748–2759. 3 indexed citations
19.
Wang, Xicheng. (2011). Bioinformatics Analysis of GRAS Gene Family in Grapevine. Guangdong nongye kexue. 3 indexed citations
20.
Wang, Xicheng, Shuling Jiang, Yufen Cao, et al.. (2010). Development of EST-Derived SSR Markers for Pear and Evaluation of Their Application in Pear Genetic Diversity Analysis. Zhongguo nongye Kexue. 43(24). 5079–5087. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kah Keng Wong Breakdown of academic impact, for papers by Fang Yu Breakdown of academic impact, for papers by Pierre Martineau Breakdown of academic impact, for papers by Sigrid Hatse Breakdown of academic impact, for papers by Bing Tian Breakdown of academic impact, for papers by Yi‐Lin Chiu Breakdown of academic impact, for papers by Susan L. Kelley Breakdown of academic impact, for papers by Shigeru Kawabata Breakdown of academic impact, for papers by Anil Tulpule Breakdown of academic impact, for papers by Chunyang Li
Rankless by CCL
2026